@article {Sullivan1474, author = {Brian T. Sullivan and Jessica A. Cherry and Hideo Sakamoto and Luiz E. Henkes and David H. Townson and Bo R. Rueda}, title = {Cytokeratin 18 Expression Inhibits Cytokine-Induced Death of Cervical Cancer Cells}, volume = {20}, number = {9}, pages = {1474--1481}, year = {2010}, doi = {10.1111/IGC.0b013e3181fc3a03}, publisher = {BMJ Specialist Journals}, abstract = {Objectives: In cervical cancer, increased cytokeratin 18 (CK18) filament expression is associated with disease progression. However, it may also provide resistance to cytokine-induced apoptosis. The present study tested whether CK18 expression influences susceptibility to cytokine-induced apoptosis.Methods: The cervical cancer cell lines C-4II (high CK18 expression), ME-180 (low CK18 expression), and 2 subtypes of HeLa cells containing or lacking CK18 expression (CK18+ and CK18- cells, respectively) were exposed to vehicle (control), Fas ligand (FasL) (50 ng/mL), or tumor necrosis factor α (TNF-α; 10 ng/mL) without/with cycloheximide (CHX; 2.5 μg/mL) to test the hypothesis that diminished CK18 expression increases susceptibility to cytokine-induced apoptosis.Results: Flow cytometric analysis of cell death via TUNEL staining revealed that cytokine-induced apoptosis was 2-fold greater in ME-180 cells than C-4II cells in response to FasL+CHX or TNF-α+CHX (P \< 0.05). Similarly, there was a higher incidence of FasL-induced apoptosis in CK18- HeLa cells (23\% and 91\% apoptotic for FasL and FasL+CHX, respectively) than CK18+ HeLa cells (1\% and 11\%, respectively; P \< 0.05). Surprisingly, TNF-α had no effect on either CK18+ or CK18- HeLa cells (P \> 0.05). Caspase 3 activity was greater in CK18- HeLa cells than in CK18+ HeLa cells at 8 and 18 hours after FasL treatment (P \< 0.05), an effect abrogated by the caspase 8 inhibitor IETD-fmk (P \< 0.05).Conclusions: Cervical cancer cells with diminished CK18 expression are more susceptible to cytokine-induced apoptosis, particularly in response to FasL treatment. These observations suggest that relative CK18 expression is an important factor when considering therapeutic strategies to enhance immune cell-mediated death of cervical cancer cells.}, issn = {1048-891X}, URL = {https://ijgc.bmj.com/content/20/9/1474}, eprint = {https://ijgc.bmj.com/content/20/9/1474.full.pdf}, journal = {International Journal of Gynecologic Cancer} }